Company Filing History:
Years Active: 2018-2025
Title: Yen-Yu Wu: Innovator in Antibody Development
Introduction
Yen-Yu Wu is a prominent inventor based in Taipei, Taiwan, known for his significant contributions to the field of biotechnology. He holds two patents that focus on innovative antibody technologies aimed at addressing critical health issues.
Latest Patents
Wu's latest patents include "Anti-CD73 antibodies and use thereof," which describes a novel antibody and its antigen-binding fragment that specifically targets human CD73. This invention has potential applications in various therapeutic areas. His second patent, "Anti-VEGFR antibody and uses thereof," relates to an antibody that binds to human vascular endothelial growth factor receptor 2 (VEGFR-2). This patent outlines methods for inhibiting VEGFR-2-mediated signaling, treating related diseases, and detecting VEGFR in samples.
Career Highlights
Yen-Yu Wu is affiliated with the Development Center for Biotechnology, where he has been instrumental in advancing research and development in antibody therapies. His work has contributed to the understanding and treatment of diseases associated with VEGFR-2 activity.
Collaborations
Wu collaborates with notable colleagues, including Szu-Liang Lai and Chun-Chung Lee, who contribute to his research endeavors and innovations in the field.
Conclusion
Yen-Yu Wu's innovative work in antibody development showcases his commitment to advancing biotechnology and improving health outcomes. His patents reflect a significant step forward in therapeutic applications, highlighting his role as a key inventor in this vital area of research.